At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
PROPEL Contour Sinus Implant +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The EXPAND Study: A Clinical Evaluation of PROPEL® Contour Sinus Implant Placement in the Frontal Sinus Ostium Following In-office Bilateral Balloon Dilation
In Brief
A clinical study evaluating PROPEL Contour Sinus Implant and Balloon Sinus Dilation Alone for Chronic Rhinosinusitis (Diagnosis). Completed, enrolled 80 participants across 14 sites.
Detailed Summary
The objective of this study is to evaluate the efficacy of PROPEL Contour placement following an in-office frontal sinus balloon dilation (SBD) in patients with chronic rhinosinusitis (CRS)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Rhinosinusitis (Diagnosis)
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedApr 2021
Enrollment StartMay 2021
Primary CompletionFeb 2022
Study CompletionJun 2022
TodayJul 2026
First PostedApr 26, 2021
Enrollment StartMay 12, 2021
Primary CompletionFeb 10, 2022
Study CompletionJun 20, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.2 years ago
Interventions
PROPEL Contour Sinus Implantdevice
370 mcg mometasone furoate-coated sinus implant
Balloon Sinus Dilation Aloneprocedure
No PROPEL Contour Sinus Implant